Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Downgrades 10x Genomics to Market Perform

William Blair Downgrades 10x Genomics to Market Perform

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.

byBenzinga Newsdesk

July 15, 2022

1 minute read

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.

Investor Sentiment Improves, But Dow Falls Over 100 Points

By Avi Kapoor

June 4, 3:23 AM

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index…

BBWI

Mizuho Reinstates Neutral on Intel, Announces $32 Price Target

By Benzinga Newsdesk

November 22, 8:23 AM

Mizuho analyst Vijay Rakesh reinstates Intel (NASDAQ:INTC) with a Neutral and announces $32 price target.

INTC

What’s Going On With Marathon Petroleum Shares Today?

By Lekha Gupta

April 30, 11:59 AM

Marathon Petroleum shares down after reporting Q1 FY24 results. Revenue at $33.211B, adjusted EPS at $2.78, operating costs increase.

FTXN

Greenland Technologies Q3 EPS $0.10 Misses $0.13 Estimate, Sales $21.80M Miss $25.45M Estimate

By Benzinga Newsdesk

November 9, 6:05 AM

Greenland Technologies (NASDAQ:GTEC) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.13 by 23.08 percent. This is a 11.11 percent increase over earnings of $0.09 per share

GTEC

William Blair Downgrades 10x Genomics to Market Perform

Related Posts

Investor Sentiment Improves, But Dow Falls Over 100 Points

Mizuho Reinstates Neutral on Intel, Announces $32 Price Target

What’s Going On With Marathon Petroleum Shares Today?

Greenland Technologies Q3 EPS $0.10 Misses $0.13 Estimate, Sales $21.80M Miss $25.45M Estimate